Comparison of Misoprostol versus Dinoprostone for delivery induction among pregnant women without concomitant disease.


Journal

Ginekologia polska
ISSN: 2543-6767
Titre abrégé: Ginekol Pol
Pays: Poland
ID NLM: 0374641

Informations de publication

Date de publication:
Historique:
received: 26 06 2020
accepted: 20 07 2020
entrez: 15 1 2021
pubmed: 16 1 2021
medline: 28 8 2021
Statut: ppublish

Résumé

Induction of labour is a part of an active prenatal care nowadays and the ideal method of that procedure still remains to be identified. The purpose of this study was to evaluate effectiveness of misoprostol vaginal insert as compared to dinoprostone gel for delivery induction in pregnant women without any comorbidities. It was a retrospective cohort study of 240 pregnant women. The primary study outcome was successful delivery. Other analysed parameters included time to delivery of a baby, time to the beginning of the first stage of labour, time to vaginal delivery, and duration of all delivery stages. We compared both methods regarding maternal complications during and after delivery. We also reviewed neonatal outcomes such as birth weight, birth length and 1-minute Apgar scores. The patients' basic characteristics were similar regarding their age, gravidity, parity, height, weight and Bishop score. Time to any delivery and to the onset of a labour in the misoprostol group versus in the dinoprostone group was 14.5 vs 35.6 h (p < 0.001) and 9.9 h vs 25.3 h (p < 0.001) respectively. The chance of the beginning of labour and the baby's delivery over time has been observed to be approximately two times higher for misoprostol as compared to dinoprostone. Our study showed that using misoprostol vaginal insert in comparison to dinoprostone seems to shorten the time to beginning of the first stage of labour as well as the time to the delivery itself. Some lower Apgar scores observed in the misoprostol group requires further investigation.

Identifiants

pubmed: 33447991
pii: VM/OJS/J/67673
doi: 10.5603/GP.2020.0119
doi:

Substances chimiques

Oxytocics 0
Misoprostol 0E43V0BB57
Dinoprostone K7Q1JQR04M

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

726-732

Auteurs

Teresa Gornisiewicz (T)

Department of Obstetrics and Perinatology, University Hospital, Cracow, Poland. tersagornisiewicz@wp.pl.

Katarzyna Kusmierska-Urban (K)

Department of Obstetrics & Perinatology, Jagiellonian University Medical College, Cracow, Poland (employed until 2019).

Hubert Huras (H)

Department of Obstetrics & Perinatology, Jagiellonian University Medical College, Cracow, Poland.

Aleksander Galas (A)

Chair of Epidemiology and Preventive Medicine, Jagiellonian University Medical College, Cracow, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH